AbbVie Inc. (ABBV) Stock Investment Calculator & Historical Return Analysis
AbbVie is a global, research-based biopharmaceutical company that originated as a spin-off of Abbott Laboratories. The company's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. They strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. Investors often view AbbVie Inc. as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.
This AbbVie Inc. stock investment calculator allows you to explore how a hypothetical investment in ABBV might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.
What if you invested $1000 in ABBV on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Understanding AbbVie Inc.'s Historical Performance
AbbVie Inc.'s stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, ABBV has experienced periods of growth driven by innovation and market demand.
When analyzing AbbVie Inc.'s historical returns, it's important to consider:
- Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
- Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
- Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations.
This calculator helps you see how these factors might have affected an investment depending on when you entered the market.
Historical Annual Returns
Over the past 14 years, AbbVie Inc. has delivered an annualized return (CAGR) of +19.4%. Its strongest year was 2017 at +60.6%, and its weakest was 2015 at -7.1%. Overall, the stock finished in the green 11 times out of 14 years.
Annualized
+19.4%
Win Rate
79%
11W - 3L
Best
+60.6%
2017
Worst
-7.1%
2015
Performance Consistency
AbbVie Inc. Annual Returns by Year
| Year | Annual Return | Start Price | End Price |
|---|---|---|---|
| 2013 | +56.38% | $21.05 | $32.92 |
| 2014 | +29.96% | $32.40 | $42.11 |
| 2015 | -7.14% | $42.39 | $39.37 |
| 2016 | +12.90% | $38.28 | $43.22 |
| 2017 | +60.61% | $43.08 | $69.19 |
| 2018 | -2.67% | $70.41 | $68.53 |
| 2019 | +4.83% | $66.33 | $69.53 |
| 2020 | +26.28% | $70.33 | $88.81 |
| 2021 | +34.61% | $87.37 | $117.60 |
| 2022 | +23.99% | $117.62 | $145.84 |
| 2023 | -0.71% | $146.53 | $145.50 |
| 2024 | +15.25% | $150.05 | $172.93 |
| 2025 | +30.84% | $174.63 | $228.49 |
| 2026 | +8.14% | $229.31 | $247.97 |
Historical annual returns for AbbVie Inc.. Each year shows the change from that year's first trading day to its last, using split- and dividend-adjusted closing prices. The current year is partial (year-to-date).
Why Use a "What If" Stock Calculator?
Many investors wonder questions such as:
- What if I had invested 5 years ago?
- How does timing affect long-term returns?
- What role does compounding play in stock investments?
A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.
Key Innovations
- ✓Imbruvica (ibrutinib), a targeted therapy for certain types of cancer.
- ✓Integration of advanced data analytics and automation into core operational workflows.
- ✓Humira (adalimumab), a biologic medication used to treat a variety of autoimmune diseases.
- ✓Strategic R&D investment driving next-generation solution design and market differentiation.
- ✓Proprietary technology architecture developed by AbbVie Inc. to optimize operational performance.
- ✓Venclexta (venetoclax), a medication for chronic lymphocytic leukemia.
- ✓Expansion of digital transformation initiatives across product engineering and customer delivery.
Business Segments
- ImmunologyThis segment includes products for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease.
- OncologyThis segment develops and markets treatments for various types of cancer.
- NeuroscienceThis segment focuses on treatments for neurological and psychiatric disorders.
How to Interpret the Results
The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can show how an investment behaved across different market cycles.
For best use:
- Compare multiple time ranges to see how outcomes differ
- Use consistent assumptions across different stocks
- Combine this tool with fundamental research and diversification principles